The primary concern is hypoglycemia, which is manageable with proper nutrition timing
Greater weight loss potential The SURMOUNT-5 trial, published in NEJM in 2025, directly compared tirzepatide against semaglutide in adults with obesity (without diabetes)
The list price of Ozempic is $968.52 for a 30-day supply, according to the manufacturer, Novo Nordisk
Thyroid Status Optimization: Before initiating weight loss injections, hypothyroidism should be adequately controlled
Join Omada Healths Chief Medical Officer, Carolyn Jasik, MD, and Clinical Pharmacist Ketan Patel, PharmD from Mercer as they share insights in how GLP-1 medications have expanded to treat additional chronic conditions, particularly CVD, and the questions that remain for how to integrate these treatments affordably and efficiently into care models